Asia-Pacific Injectable Drug Delivery Market - Industry Trends and Forecast to 2029

Market Analysis and Insights : Asia-Pacific Injectable Drug Delivery Market

Asia-Pacific injectable drug delivery market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 11.45% in the above mentioned forecast period and is expected to reach the USD 297.31 billion by 2029.

Formulations, technologies, procedures and systems for conveying a pharmaceutical ingredient in the body are collectively referred to as drug delivery. Needle-free injectors, pen injectors, auto injectors, and traditional syringes are among the injectable drug delivery systems.

One of the major factors likely to accelerate the growth and demand of the injectable drug delivery industry is the spike in sales for self-injection devices. Furthermore, the worldwide market is growing due to an increase in the incidence of chronic diseases such as diabetes and cancer. The growing need for drug delivery methods, rising healthcare expenditure and increase in research and development activities are the major factors influencing the market growth rate. The growing demand for injectables in treating large variety of disorders including Wilson's disease, autoimmune diseases, haemophilia, hepatitis C, and cystic fibrosis will further boost the market's growth.

Moreover, the high demand for biosimilar and generic injectable, quick scientific innovations and new product releases, and strong growth in the biologics industry will provide beneficial opportunities for the Injectable drug delivery market in the forecast period of 2022-2029.

However, the different infections connected with needle stick injuries and product recalls, are the factors that will hinder the market growth. The rise in demand for other forms of drug delivery will further challenge the Injectable drug delivery market in the forecast period mentioned above.

This Asia-Pacific injectable drug delivery market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Asia-Pacific injectable drug delivery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Asia-Pacific Injectable Drug Delivery Market Scope and Market Size

The Asia-Pacific injectable drug delivery market is segmented on the basis of type, formulation packaging, therapeutic application, usage pattern, site of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type, the injectable drug delivery market is segmented into injectable drug delivery devices and injectable drug delivery formulation. Injectable drug delivery devices have further been segmented into conventional injection devices and self-injection devices. Self-injection devices have further been sub-segmented into needle-free injectors, auto injectors, pen injectors, wearable injectors and others. Injectable drug delivery formulation has further been segmented into conventional drug delivery formulation, novel drug delivery formulation and long-acting injection formulations. Novel drug delivery formulation has further been sub-segmented into colloidal dispersions and microparticles. Colloidal dispersions are further divided into niosomes, liposomes, polymeric/mixed micelles and nanoparticles. Micro particles are further divided into microspheres and microcapsules.
• On the basis of formulation packaging, the injectable drug delivery market is segmented into ampoules, vials, cartridges and bottles.
• Based on therapeutic application, the injectable drug delivery market is segmented into autoimmune diseases, hormonal disorders, orphan diseases, cancer and others.
• On the basis of usage pattern, the injectable drug delivery market is segmented into curative care, immunization and others.
• Based on site of administration, the injectable drug delivery market is segmented into skin, circulatory/musculoskeletal system, organs and central nervous system.
• On the basis of end-users, the injectable drug delivery market is segmented into clinic, hospital and others.
• The injectable drug delivery market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Asia-Pacific Injectable Drug Delivery Market Country Level Analysis

Asia-Pacific injectable drug delivery market is analyzed and market size information is provided by the country, type, formulation packaging, therapeutic application, usage pattern, site of administration, end-users and distribution channel as referenced above.

The countries covered in the Asia-Pacific injectable drug delivery market report are the Japan, China, India, South Korea, Australia, Thailand, Malaysia, Singapore, Indonesia, Philippines, Rest of Asia-Pacific.

China dominates the Asia-Pacific injectable drug delivery market due to the rising population, changing lifestyle and upsurge in the adoption rate of developed technologies.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Asia-Pacific injectable drug delivery market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Asia-Pacific Injectable Drug Delivery Market Share Analysis

Asia-Pacific injectable drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Asia-Pacific injectable drug delivery market research.

Some of the major players operating in the Asia-Pacific injectable drug delivery market are Pfizer Inc., Teva Pharmaceutical Industries Ltd., Baxter, BD, SCHOTT AG, Gerresheimer AG, Alkermes, Eli Lilly and Company, Sandoz, Terumo Corporation, Ypsomed AG and Bespak Europe Ltd., among others.

SKU-1492